China smartphone shipments slumped in June on inventory overhang: Jefferies
SUNNYVALE, Calif.— Intuitive Surgical Inc . (NASDAQ:ISRG), a medical technology company currently valued at $184.7 billion and showing strong financial health according to InvestingPro metrics, reported that Senior Vice President and Chief Manufacturing and Supply Chain Officer, Mark Brosius, has sold shares of the company, according to a recent SEC filing. On March 7, Brosius sold 489 shares of Intuitive Surgical common stock at an average price of $533.18 per share, totaling approximately $260,725.
Following this transaction, Brosius retains direct ownership of 2,091 shares in the company. The sale was conducted under a pre-arranged trading plan compliant with SEC Rule 10b5-1, which allows company insiders to set up a predetermined plan for selling stocks. This plan is set to expire on June 13, 2025.
In other recent news, Intuitive Surgical reported a robust fourth-quarter performance for 2024, surpassing expectations with a 10% and 24% increase in revenue and earnings per share (EPS), respectively. The company also provided guidance for 2025, projecting a 13-16% increase in procedure volume, aligning with its historical trend of conservative initial targets. RBC Capital Markets maintained an Outperform rating with a $641 price target, while Piper Sandler increased its price target to $670, reflecting confidence in the company’s future prospects. Bernstein analysts also affirmed an Outperform rating, setting an ambitious $700 price target, following a 38% year-over-year increase in EPS to $2.21.
Truist Securities updated its outlook on Intuitive Surgical, raising the price target to $666 and maintaining a Buy rating, despite some anticipated challenges in gross margins and currency exchange impacts. Oppenheimer, however, maintained a Perform rating, citing concerns about market saturation and the premium pricing of the new da Vinci (EPA:SGEF) 5 system. The anticipated mid-2025 launch of the da Vinci 5 system is seen as a pivotal event for the company’s growth strategy. Additionally, Intuitive Surgical secured a significant €290 million distribution agreement, expected to enhance its presence in Italy, Spain, and Portugal. These developments underscore Intuitive Surgical’s ongoing efforts to capitalize on its strong market position and growth trajectory.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.